Gsk (GSK) Operating Margin (2016 - 2025)
Historic Operating Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 30.34%.
- Gsk's Operating Margin rose 279800.0% to 30.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.41%, marking a year-over-year increase of 53900.0%. This contributed to the annual value of 12.82% for FY2024, which is 94200.0% down from last year.
- Gsk's Operating Margin amounted to 30.34% in Q3 2025, which was up 279800.0% from 25.33% recorded in Q2 2025.
- In the past 5 years, Gsk's Operating Margin registered a high of 61.57% during Q4 2021, and its lowest value of 2.36% during Q3 2024.
- Over the past 5 years, Gsk's median Operating Margin value was 23.9% (recorded in 2022), while the average stood at 25.11%.
- As far as peak fluctuations go, Gsk's Operating Margin tumbled by -376800bps in 2022, and later surged by 279800bps in 2025.
- Gsk's Operating Margin (Quarter) stood at 61.57% in 2021, then plummeted by -61bps to 23.9% in 2022, then grew by 25bps to 29.89% in 2023, then crashed by -31bps to 20.57% in 2024, then soared by 48bps to 30.34% in 2025.
- Its last three reported values are 30.34% in Q3 2025, 25.33% for Q2 2025, and 29.48% during Q1 2025.